Physician profile
Eric B Larios
NPI 1720512221
$2,693.13
in general payments reported to CMS, 2019-2025
21 companies · $824 in 2025
The $824 reported for 2025 was more than what 88% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $415 · 2020: $223 · 2021: $268 · 2022: $269 · 2023: $217 · 2024: $478 · 2025: $824.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,519.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,518.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $376.20 | 2019-2025 | |
| Alcon Vision LLC | $318.63 | 2022-2025 | Rocklatan, Hydrus Microstent, Eysuvis |
| Kala Pharmaceuticals, INC. | $302.35 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $267.44 | 2019-2023 | |
| Bausch & Lomb Americas INC. | $215.41 | 2023-2025 | Xiidra, Vyzulta, Infuse |
| Rxsight INC | $201.84 | 2023-2025 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens |
| Oyster Point Pharma, INC. | $147.60 | 2022-2024 | Tyrvaya, Ryzumvi |
| Thea Pharma INC. | $116.65 | 2024-2025 | Iyuzeh |
| Tarsus Pharmaceuticals, INC. | $113.40 | 2024-2025 | Xdemvy |
| Dompe US, INC. | $111.35 | 2022-2025 | Oxervate |
| Aerie Pharmaceuticals, INC. | $105.06 | 2019-2021 | |
| Harrow Eye, LLC | $94.59 | 2024-2025 | Vevye |
| Astellas Pharma US INC | $93.76 | 2024-2025 | Izervay |
| Abbvie INC. | $63.12 | 2025 | |
| Allergan, INC. | $55.42 | 2020-2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $20.30 | 2019 | |
| Sight Sciences, INC. | $19.73 | 2022 | |
| Johnson & Johnson Surgical Vision, INC. | $19.34 | 2025 | Tecnis Iol, Tecnis Simplicity |
| Biotissue Holdings INC. | $18.38 | 2023 | |
| Eyevance Pharmaceuticals LLC | $17.02 | 2020 | |
| Ani Pharmaceuticals, INC. | $15.54 | 2024 | Purified Cortrophin Gel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Larios listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.